Concepedia

Boris Freydin

BF

11

Publications

571

Citations

11

H-Index

2010

Active since

Affiliations

Thomas Jefferson University(Current)

Sidney Kimmel Cancer Center

Walter Reed National Military Medical Center

Windber Research Institute

Duke University

Boris Freydin is an author at Thomas Jefferson University specializing in medicine, tumor biology, and tumor microenvironment.

Top concepts

Publications per year

2010–2020

11

Publications

11

Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma

Matías E. Valsecchi, Mary Jane McDonald, Jonathan R. Brody et al. · Cancer · 2011 · 115 citations · Full text

Loss of Nuclear Localized and Tyrosine Phosphorylated Stat5 in Breast Cancer Predicts Poor Clinical Outcome and Increased Risk of Antiestrogen Therapy Failure

Amy R. Peck, Agnieszka K. Witkiewicz, Chengbao Liu et al. · Journal of Clinical Oncology · 2011 · 102 citations · Full text

HuR Status is a Powerful Marker for Prognosis and Response to Gemcitabine-Based Chemotherapy for Resected Pancreatic Ductal Adenocarcinoma Patients

Nathan Richards, David Rittenhouse, Boris Freydin et al. · Annals of Surgery · 2010 · 95 citations

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes

Amy R. Peck, Agnieszka K. Witkiewicz, Chengbao Liu et al. · Breast Cancer Research · 2012 · 75 citations · Full text

Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence

Agnieszka K. Witkiewicz, Boris Freydin, Inna Chervoneva et al. · Cancer Biology & Therapy · 2010 · 46 citations

Rows per page

1–5 of 11